VIPR2 associated_with schizophrenia
Evidence from:
primary |
all sources
Evidence (1 sources)
One new drug target recently identified in schizophrenia is the Vasoactive Intestinal Peptide Receptor-2 (VIPR2)
confidence: 0.85
One new drug target recently identified in schizophrenia is the Vasoactive Intestinal Peptide Receptor-2 (VIPR2)